HCID 10508355, compound → HCID 178439940, compound

Participants

Reaction Steps

A 359 mg portion of the mixed product obtained in Example 6 consisting (about 2:1) of 6-methyl-2-propyl-5-[[2'-(N-triphenylmethyl-tetrazol-5-yl)biphenyl-4-yl]methyl]-5H-pyrazolo[1,5-b][1,2,4]triazole (compound 6c) and 6-methyl-2-propyl-1H-pyrazolo[1,5-b][1,2,4]triazole was treated in the same manner as described in Example 23 to give 126 mg of 6-methyl-2-propyl-5-[[2'-(tetrazol-5-yl)biphenyl-4-yl]methyl]-5H-pyrazolo[1,5-b][1,2,4]triazole in the form of colorless crystals.

Provenance & Evidence